Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 29 (16), 2232-2235
- https://doi.org/10.1016/0959-8049(93)90212-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Weight loss in patients with hematological neoplasias is associated with immune system stimulationJournal of Molecular Medicine, 1993
- Interferon‐γ induces cell surface expression for both types of tumor necrosis factor receptorsFEBS Letters, 1992
- Soluble Tumor Necrosis Factor Receptors Correlate with Parasitemia and Disease Severity in Human MalariaThe Journal of Infectious Diseases, 1992
- Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cellsInternational Journal of Cancer, 1991
- HAEMOPOIETIC GROWTH FACTORS 1The Lancet, 1989
- High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia [see comments]Blood, 1989
- Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical ApplicationAdvances in Clinical Chemistry, 1989
- Cancer CachexiaPublished by Springer Science and Business Media LLC ,1989
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975